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Abstract
Rasa3 is a GTPase activating protein of the GAP1 family which targets Ras and Rap1. Ubiquitous Rasa3 catalytic inactivation
in mouse results in early embryonic lethality. Here, we show that Rasa3 catalytic inactivation in mouse hematopoietic cells
results in a lethal syndrome characterized by severe defects during megakaryopoiesis, thrombocytopenia and a
predisposition to develop preleukemia. The main objective of this study was to define the cellular and the molecular
mechanisms of terminal megakaryopoiesis alterations. We found that Rasa3 catalytic inactivation altered megakaryocyte
development, adherence, migration, actin cytoskeleton organization and differentiation into proplatelet forming
megakaryocytes. These megakaryocyte alterations were associated with an increased active Rap1 level and a constitutive
integrin activation. Thus, these mice presented a severe thrombocytopenia, bleeding and anemia associated with an
increased percentage of megakaryocytes in the bone marrow, bone marrow fibrosis, extramedular hematopoiesis,
splenomegaly and premature death. Altogether, our results indicate that Rasa3 catalytic activity controls Rap1 activation
and integrin signaling during megakaryocyte differentiation in mouse.
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Introduction
Ras families GTPase-activating proteins (GAP), like Ras GAPs,
Rho GAPs and Arf GAPs, are tumor suppressors as the loss of
their GAP activity allows uncontrolled Ras, Rho and Arf activities
and promotes cancer. Rasa3 (or GAP1IP4BP, R-Ras GAP) is a
member of the Ras GAP1 subfamily with Rasa2 (or GAP1m),
Rasa4 (or Capri) and Rasal (or Rasal1) [1–5]. This Ras GAP
subfamily is known to function as dual GAP for Ras an Rap-
GTPases [6,7]. Rasa3 protein structure is characterized by a
conserved basic domain structure comprising two N-terminal
tandem C2 domains, a central GAP domain and a C-terminal
pleckstrin homology (PH) domain that is associated with a
Bruton’s tyrosine kinase (Btk) motif [8]. Binding of the latter
domain to phosphoinositides determines Rasa3 targeting to the
cytosolic leaflet of the plasma membrane where it inactivates Ras
and Rap1 [9–11]. Down-regulation of Rasal and Rasa4 induces
cellular transformation in vitro [12,13], and Rasal is down-
regulated in multiple human tumors by epigenetic silencing [14].
Rasa4 inactivation in mouse leads to impaired macrophages Fcc
receptor-mediated phagocytosis and oxidative burst, as well as to
increased bacterial infection [15]. No clear definition of Rasa2
function in vivo is currently available. Mutant mice expressing a
catalytically-inactive Rasa3 protein have been reported to die at
mid embryonic life [16]. Indeed, removal of exons 11 and 12 of
the mouse Rasa3 gene, 2 exons which are essential for the Ras
GAP activity, leads to the expression of a 88 amino acids-
truncated but catalytically inactive Rasa3 protein [16]. Phenotyp-
ically, Rasa3 mutant embryos present massive subcutaneous and
intraparenchymal hemorrhages probably consecutive to abnormal
adherens junctions between capillary endothelial cells [16].
Multiple roles for Ras and Rap1, the Rasa3 targets, have been
defined in hematopoietic cells: these proteins control cellular
proliferation, differentiation, migration and adhesion. In particu-
lar, Rap1 has been implicated in the maturation of megakaryo-
cytes and the pathogenesis of chronic myelogenous leukemia [17].
Here, we found that catalytic inactivation of Rasa3 specifically in
the hematopoietic system results in a lethal syndrome character-
ized by major alterations during megakaryopoiesis. These
alterations were associated with increased active Rap1 level and
constitutive integrin activation in megakaryocytes, a phenotype
quite different clinically, biologically and mechanistically from that
of recently published mice with a spontaneous missense mutation
between the two N-terminal tandem C2 domains of Rasa3 [18].
Results
The SCID-Rasa3 model
In order to study the specific effects of a catalytically-inactive
Rasa3 mutant protein on the hematopoietic system and to
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circumvent the early embryonic lethality reported in Rasa32/2
mice, we used irradiated Severe Combined Immune Deficient
(SCID) mice reconstituted with E12.5 liver cells derived from
Rasa3+/+, Rasa3+/2 or Rasa32/2 embryos. SCID mice were first
analyzed 6 weeks after irradiation/reconstitution: all Rasa3
genotypes were able to reconstitute the lymphoid compartment
in irradiated SCID mice since no significant difference was
detected between SCID-Rasa3+/+, SCID-Rasa3+/2 and SCID-
Rasa32/2 mice in total numbers of splenic T and B cells (Table
S1). No significant difference was observed in red blood cell, blood
platelet and bone marrow megakaryocyte counts as well as spleen
weight between SCID-Rasa3+/+ and SCID-Rasa32/2 mice at this
stage (Table S1).
Decreased survival, hemorrhages and splenomegaly in
SCID-Rasa32/2 mice
More than 80% of SCID mice reconstituted with Rasa32/2
cells died within 14 months after reconstitution while, at the same
time, about 95% of SCID-Rasa3+/+ and SCID-Rasa3+/2 mice
were still alive (Fig. 1a). Pathological analysis revealed that 85% of
SCID-Rasa32/2 mice presented with thoracic and/or peritoneal
hemorrhages (data not shown) and that more than 80% had a
splenomegaly (Fig. 1b). Our results below present the analysis of a
total of 24 moribund SCID-Rasa32/2 mice. Among these 24
mice, 20 had a megakaryocytic dysplasia associated with a severe
thrombocytopenia, and the remaining 4 developed a preleukemia.
The main objective of this study was to define the cellular and the
molecular mechanisms of the megakaryocytic dysplasia.
Thrombocytopenia and megakaryocyte alterations in 20/
24 SCID-Rasa32/2 mice
In ,80% (20/24) of SCID-Rasa32/2 mice, blood analysis
revealed a thrombocytopenia (Fig. 1c). Thrombocytopenia in these
mice was associated with megakaryocyte alterations. A significant
increase in the percentage of CD41+ megakaryocytes was observed
in the bone marrow of SCID-Rasa32/2 mice (Fig. 1d). These
megakaryocytes were morphologically abnormal and presented a
marked increase in the intensity of von Willebrand factor (vWF)
staining, as compared with SCID-Rasa3+/+ megakaryocytes
(Fig. 1e). vWf+ deposits were also abnormally detected along the
SCID-Rasa32/2 diaphysis (Fig. 1e, arrowheads). In addition,
more megakaryocytes were present in the osteoblastic niche in
SCID-Rasa32/2 mice, as compared with SCID-Rasa3+/+ mice
(Fig. 1f, left panel). Inversely, the vascular niche hosted less
megakaryocytes in mutant mice (Fig. 1f, right panel). The stem
and megakaryocyte progenitor cell compartments were charac-
terized in the bone marrow of SCID-Rasa3+/+ and SCID-
Rasa32/2 mice by flow cytometry. A similar percentage of live
c-Kit+/Lin2 cells was detected in the bone marrow of these mice,
and the proportion of Sca-1+ cells within this population was also
not significantly different in SCID-Rasa3+/+ and SCID-Rasa32/2
mice (Table S2). Staining of these c-Kit+ Lin2 Sca-1+ (KLS) cells
with CD34 and Flk-2 antibodies defined the KLS-CD342 Flk-22
hematopoietic stem cell compartment; but again, no difference
was detected in the percentage of these cells between SCID-
Rasa3+/+ and SCID-Rasa32/2 mice (Table S2). It has been
recently shown that bone marrow progenitors with megakaryocyte
potential reside in the Lin2 c-Kit+ FccRII/IIIlo Sca-12 CD150+
cell population [19]. This cell population was decreased in the
bone marrow of SCID-Rasa32/2 mice, as compared with SCID-
Rasa3+/+, but the difference did not reach statistical significance
(Table S2).
Femur sections revealed the presence of a fibrosis characterized
by numerous collagen trabeculae in the cavity of SCID-Rasa32/2
femurs, while the cavity of SCID-Rasa3+/+ femurs was totally free
of collagen trabeculae (Fig. S1a). Consequently, the number of
nucleated cells recovered on average from one femur of SCID-
Rasa32/2 mice was significantly reduced, as compared with
SCID-Rasa3+/+ mice (SCID-Rasa3+/+: 20.962.86106 nucleated
cells, n = 12; SCID-Rasa32/2: 6.461.16106 nucleated cells,
n = 19; P,0.001, unpaired t test). Bone marrow cell density was
similar in the cavity of SCID-Rasa3+/+ and SCID-Rasa32/2
femurs (Fig. S1b), and similar percentages of CD117+/c-Kit+
progenitor cells and Ter119+ CD71+ erythroblasts were detected
in SCID-Rasa3+/+ and SCID-Rasa32/2 bone marrow cells (Table
S2 and data not shown). An increased splenic hematopoiesis -
including megakaryopoiesis -, associated with a disorganized pulp
architecture, and foci of liver hematopoiesis were also observed in
SCID-Rasa32/2 mice (Table S3 and Fig. S2).
Thrombocytopenia and hemorrhages in SCID-Rasa32/2 mice
were associated with a regenerative anemia, whereas normal
counts were maintained for total white blood cell and circulating
neutrophil, lymphocyte, monocyte and eosinophil (Fig. S3 and
Table S4). Thrombopoietin (TPO) levels were significantly
decreased in SCID-Rasa32/2 mice, as compared with SCID-
Rasa3+/+ mice, a probable consequence of the markedly increased
Mpl+/CD150+ megakaryocyte number in the spleen of these mice
(TPO level in SCID-Rasa3+/+ mice: 17326211 pg/ml, n = 11;
TPO level in SCID-Rasa32/2 mice: 653674 pg/ml, n = 16;
mean 6 SEM; P,0.001).
Collectively, our results indicate that the loss of Rasa3 catalytic
activity in 20/24 SCID-Rasa32/2 mice leads to megakaryocyte
alterations, to thrombocytopenia, hemorrages and a regenerative
anemia.
Altered megakaryocyte adhesion, motility and capacity
to differentiate in proplatelet forming megakaryocytes in
SCID-Rasa32/2 mice
Bone marrow was isolated from SCID-Rasa3 mice 2 months
after irradiation/reconstitution and cultured under a confocal
microscope. Despite a ,2-fold increased percentage of megakar-
yocytes in the SCID-Rasa32/2 bone marrow, there was a trend
for a decreased number of megakaryocytes released from
Author Summary
Megakaryocytes are the bone marrow cellular precursors
of circulating blood platelets and give rise to nascent
platelets by forming branching filaments called proplate-
lets. Terminal differentiation of round megakaryocytes into
branched proplatelet forming megakaryocytes is a com-
plex cytoskeletal-driven process which is affected in rare
human familial thrombocytopenias. Interactions of mega-
karyocytes with extracellular matrix proteins are essential
in this process since constitutive megakaryocyte integrin
activity caused by specific mutations in ITGA2B or ITGB3
genes encoding for extracellular matrix protein receptors
may result in abnormal adherent megakaryocytes, defect
in proplatelet formation and thrombocytopenia. Here, we
show that Rasa3, a GTPase activating protein of the GAP1
family, controls Rap1 activation and integrin signaling
during megakaryocyte differentiation. We found that
Rasa3 catalytic inactivation in mice altered megakaryocyte
development, adherence, migration, actin cytoskeleton
organization and differentiation into proplatelet. Thus,
these mice presented a severe thrombocytopenia, bleed-
ing and anemia.
Rasa3 in Megakaryopoiesis
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SCID-Rasa32/2 bone marrow explants, as compared with SCID-
Rasa3+/+ explants (Fig. 2a, left panel). Released SCID-Rasa32/2
megakaryocytes were able to spread on the culture plate but never
fully differentiated in proplatelet forming megakaryocytes (Fig. 2a,
centre and right panels, and Fig. 2b). The linear distance covered
by the released megakaryocytes and their velocity were signifi-
cantly lower in SCID-Rasa32/2 than in SCID-Rasa3+/+ explants
(Fig. 2c).
Altered actin cytoskeletal organization in Rasa32/2
adherent megakaryocytes
In order to further analyze the role of Rasa3 in megakaryocyte
adhesion and differentiation, we used megakaryocytes obtained
from Rasa3+/+ and Rasa32/2 fetal liver cells (FLC) cultured in the
presence of TPO. This cellular model is simpler and faster than
the model of bone marrow explants isolated from SCID-Rasa3
mice, and it recapitulated the megakaryocyte defects previously
observed in the later model. Indeed, after 2 days of TPO
treatment, flow cytometry analysis detected a significant 1.42-fold
increase in the percentage of CD41+ megakaryocytes in the
Rasa32/2 FLC culture, as compared with Rasa3+/+ culture
(Fig. 3a). CD41+ megakaryocytes with 16N and 32N ploidy were
significantly increased in these Rasa32/2 FLC cultures, as
compared with Rasa3+/+ FLC cultures (Fig. 3b). Colony-forming
unit-megakaryocyte (CFU-Mk) assay using FLC revealed a
significant decrease in the number of small immature megakar-
yocyte colonies in Rasa32/2 cell culture, as compared with
Rasa3+/+ cell culture (Fig. 3c). However, numerous large mature
megakaryocytes were detected in the Rasa32/2 CFU-Mk assay,
while not in the Rasa3+/+ CFU-Mk assay (Fig. 3c, arrowheads).
After 6 days of TPO treatment, many proplatelets were observed
in the Rasa3+/+ FLC culture whereas, in the Rasa32/2 FLC
culture, no proplatelets were detected (Fig. 3d). Instead of
proplatelets, many abnormal adherent cells were detected in the
Rasa32/2 FLC culture that were CD41 positive, indicating their
megakaryocyte origin (Fig. 3d, lower panels and Fig. 3e).
Figure 1. Decreased survival, splenomegaly, thrombocytopenia and megakaryocyte alterations in SCID-Rasa32/2mice. A. Survival of
irradiated SCID mice reconstituted with Rasa3+/+ (SCID-R3+/+, n = 28 mice), Rasa3+/2 (SCID-R3+/2, n = 31 mice) or Rasa32/2 (SCID-R32/2, n = 32 mice)
embryonic liver cells. B. Spleen weight from age-matched SCID-Rasa3+/+ and moribund SCID-Rasa32/2 mice. The mean 6 SEM are also presented in
each group of mice. A splenomegaly was defined as a spleen weight over 0.168 g (i.e. twice the mean spleen weight of SCID-Rasa3+/+ mice). C. Blood
platelet counts in age-matched SCID-Rasa3+/+ (black column, n = 9) and moribund SCID-Rasa32/2 (white column, n = 15) mice. Results represent the
mean6 SEM of platelets per ml of blood. D.Mean6 SEM of CD41+ megakaryocyte (MK) percentages detected by flow cytometry in the bone marrow
isolated from age-matched SCID-Rasa3+/+ (black column, n = 17) and moribund SCID-Rasa32/2 (white column, n = 20) femurs. E. vWF-stained bone
marrow sections of SCID-Rasa3+/+ and SCID-Rasa32/2 femurs 3 months after SCID mice reconstitution. V: vessel; *: megakaryocyte; arrowheads:
abnormal vWF deposits. Scale bars: 50 mm. F. Quantification of megakaryocytes (MKs) in the osteoblastic and the vascular niches of SCID-Rasa3+/+
(black columns) and SCID-Rasa32/2 (white columns) bone marrow femurs 3 months after irradiation/reconstitution. Results represent the mean 6
SEM of the number of megakaryocytes per unit of osteoblastic border, or per vessel. Statistics (unpaired t test): *: P,0.05; **: P,0.01; ***: P,0.001.
doi:10.1371/journal.pgen.1004420.g001
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Actin cytoskeleton staining of these abnormal adherent Rasa32/
2 megakaryocytes revealed a unique dotted actin pattern without
stress fiber at the contact with the culture plate, significantly
different from the expected actin stress fiber pattern observed in
the few adherent Rasa3+/+ megakaryocytes present in the FLC
culture at day 6 of TPO treatment (Fig. 4a, bottom, and 4b). The
actin cytoskeletal organization was also altered at the top of the
adherent Rasa32/2 megakaryocytes: actin was decreased at the
periphery and much more concentrated at the center of the cell,
as compared with adherent Rasa3+/+ megakaryocytes (Fig. 4a,
top).
Collectively, these results indicate that Rasa32/2 FLC abnor-
mally develop into mature megakaryocytes, and that Rasa32/2
megakaryocytes derived from FLC culture have an altered actin
cytoskeleton organization associated with an abnormal adherent
phenotype, a reduced motility and an absence of normal terminal
differentiation in proplatelets. Interestingly, this Rasa32/2 mega-
karyocyte phenotype (i.e. defect in proplatelet formation, dotted
actin cytoskeletal pattern with reduced stress fibers and abnormal
adherent megakaryocytes) resembles that of rare thrombocytope-
nic patients with a constitutive aIIbb3 integrin activity caused by
specific mutations in ITGA2B or ITGB3 genes [20–22].
Altered inside-out and outside-in integrin signaling in
Rasa32/2 megakaryocytes
Soluble fibrinogen binding to aIIbb3 integrin present at the
megakaryocyte surface is regulated by inside-out signaling which
determines the affinity/avidity of the integrin for its ligand. In the
absence of megakaryocyte stimulation, only little amount of
soluble FITC-fibrinogen bound to day 3 FLC culture-derived
Rasa3+/+ mature megakaryocytes (Fig. 5a). By contrast, in this
resting condition, a larger amount of soluble FITC-fibrinogen
bound to Rasa32/2 mature megakaryocytes, reaching the binding
level of Rasa3+/+ megakaryocytes when stimulated by TPO for
30 min (Fig. 5a). Stimulation of Rasa32/2 mature megakaryocytes
by TPO did not further increase soluble FITC-fibrinogen binding.
Importantly, no difference in aIIb/CD41 surface expression was
detected by flow cytometry between day 3 FLC-derived Rasa3+/+
and Rasa32/2 mature megakaryocytes (Rasa3+/+: 1234670
arbitrary units (A. U.), Rasa32/2: 10846244 A. U., n = 3
independent experiments, P = 0.11), suggesting that Rasa32/2
megakaryocytes have a constitutively activated inside-out signaling
leading to a constitutive binding of soluble fibrinogen to aIIbb3
integrin. Staining of day 3 FLC culture-derived Rasa3+/+ and
Rasa32/2 mature megakaryocytes with the JON/A antibody,
Figure 2. Altered SCID-Rasa32/2 megakaryocyte motility, adhesion and differentiation into proplatelet forming megakaryocytes.
Femur bone marrow explants were isolated from SCID-Rasa3+/+ and SCID-Rasa32/2mice 2 months after irradiation/reconstitution and cultured under
a confocal microscope. Images were taken in bright field every 10 min. A. Number of megakaryocytes released from the explants (left panel), of
spreading megakaryocytes (center panel) and of proplatelet forming megakaryocytes (right panel). Results are representative of 3 independent
experiments. B. Example of megakaryocytes released from a SCID-Rasa3+/+ (upper panels) and a SCID-Rasa32/2 (lower panels) explant. The asterisk
indicates the same megakaryocyte that finally develops into a proplatelet forming megakaryocyte (SCID-Rasa3+/+ explants) or that continuously
adheres to the culture plate and fail to form proplatelets (SCID-Rasa32/2 explants). Insets: higher magnification shows the proplatelet forming
megakaryocyte in the SCID-Rasa3+/+ explants and the adherent megakaryocyte in the SCID-Rasa32/2 explants. Scale bars: 50 mm. C. Velocity and
linear distance covered by individual megakaryocytes 3 hours after release from SCID-Rasa3+/+ and SCID-Rasa32/2 explants. Statistics (unpaired t
test): *: P,0.05; ***: P,0.001.
doi:10.1371/journal.pgen.1004420.g002
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which selectively binds to the high affinity conformation of integrin
aIIbb3, confirmed this hypothesis: a significant increase of JON/
A+ megakaryocyte percentage was detected in Rasa32/2 mega-
karyocytes in resting and TPO-stimulated conditions, as compared
with Rasa3+/+ megakaryocytes (percentage of JON/A+ megakar-
yocytes, mean 6 SEM: non-stimulated Rasa3+/+ megakaryocytes:
14.061.9%; non-stimulated Rasa32/2 megakaryocytes:
70.163.4%, P = 0.002; TPO-stimulated Rasa3+/+: 23.360.5%;
TPO-stimulated Rasa32/2 megakaryocytes: 73.163.4%,
P = 0.02).
Integrin activation triggers megakaryocyte adhesion to immo-
bilized integrin ligands like collagen-I or fibrinogen and an
outside-in signaling, resulting in the reorganization of the actin
filaments and the modification of the cell shape [23]. Megakar-
yocytes from FLC-Rasa3+/+ cultured on day 3 adhered to
collagen-I- and fibrinogen-coated plates, but nearly not to Poly-
D-Lysine-coated plates, as expected (Fig. 5b). Adherence to
immobilized collagen-I and fibrinogen resulted in cell spreading
reaching diameters over 50 mm in a limited number of Rasa3+/+
megakaryocytes, as described (Fig. 5c, red dots, and Fig. 5d) (24).
Adherence to Poly-D-Lysine-, collagen-I- and fibrinogen-coated
plates was significantly higher in Rasa32/2 than in Rasa3+/+
megakaryocytes (Fig. 5b). The percentage of megakaryocytes with
a diameter over 50 mm was significantly increased in the Rasa32/2
culture, as compared with the Rasa3+/+ culture (Fig. 5d). Outside-in
integrin activation triggers the binding of the cytoskeletal protein
talin to membrane integrins [24]. In association with their abnormal
adhesion properties, Poly-D-Lysine adherent Rasa32/2 megakar-
yocyte recruited more talin to their membrane, as compared with
Rasa3+/+ megakaryocytes (Fig. 5e)
Collectively, our results indicate that Rasa32/2 megakaryocytes
have a constitutively activated inside-out aIIbb3 integrin signaling
associated with major alterations in outside-in integrin signaling
leading to cell adherence and spreading independently of integrin
ligands.
Increased active GTP-bound Rap1 in Rasa32/2 adherent
megakaryocytes
Since the small GTPase Rap1, a Rasa3 substrate, controls
inside-out and outside-in integrin signaling in megakaryocytes and
Figure 3. Abnormal megakaryocyte differentiation from Rasa32/2 fetal liver cell culture. Fetal liver cell (FLC) were isolated from E12.5
Rasa3+/+ and Rasa32/2 embryos. A. Percentages of CD41+ megakaryocytes were determined at day 0 and 2 days after TPO treatment in 6 Rasa3+/+
and 8 Rasa32/2 FLC cultures by flow cytometry. Results are expressed as fold of increase of CD41+ cells, considering the percentage of Rasa3+/+
CD41+ cells at day 0 as 1. Statistics (unpaired t test): **: P,0.01. B. Increased megakaryocyte ploidy in FLC culture at day 2 after TPO treatment.
Representative images of DNA content in Rasa3+/+ and Rasa32/2 CD41+ megakaryocytes. The table shows a quantification of the percentages of
individual ploidy classes of FLC-derived CD41+ megakaryocytes (mean 6 SEM). Statistics (unpaired t test, n = 6): *: P,0.013; ***: P,0.009. C. CFU-Mk
assay from Rasa3+/+ and Rasa32/2 FLC. Representative images of a Rasa3+/+ CFU-Mk with immature megakaryocytes of about 10 mm of diameter, and
of Rasa32/2 mature megakaryocytes of about 30 mm of diameter (arrowheads). Scale bars: 50 mm. The graph represents the number of CFU-Mk
formed by 5 Rasa3+/+ and 3 Rasa32/2 independent FLC cultures after 3 days (mean 6 SEM). Statistics (unpaired t test): **: P,0.01. D. Representative
images of FLC Rasa3+/+ (upper panels) and Rasa32/2 (lower panels) cultures after 6 days with TPO. A digital magnification (36) of a proplatelet event
in Rasa3+/+ FLC culture (right upper panel) and of an abnormal adherent megakaryocyte in Rasa32/2 FLC culture (right lower panel) are presented. In
Rasa3+/+ FLC culture, 8.462.2% of megakaryocytes formed proplatelets. No proplatelet forming megakaryocyte was detected in Rasa32/2 FLC
culture. Scale bars: 50 mm. E. Rasa3+/+ (upper panels) and Rasa32/2 (lower panels) FLC cultures after 6 days with TPO were stained with a CD41
antibody (green, left panels) or CD41 and DAPI (green and blue, respectively; right panels). The large abnormal adherent cell population detected in
Rasa32/2 FLC culture is CD41-positive. In Rasa3+/+ FLC culture, 8.462.2% of megakaryocytes formed proplatelets. No proplatelet forming
megakaryocyte was detected in Rasa32/2 FLC culture. Scale bars: 50 mm.
doi:10.1371/journal.pgen.1004420.g003
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platelets [25–29], the level of active, GTP-bound Rap1 was
analyzed in mature Rasa3+/+ and Rasa32/2 megakaryocytes. A
significant 2 fold-increase in active Rap1 was observed in
Rasa32/2 megakaryocytes, as compared with Rasa3+/+ mega-
karyocytes, providing a molecular mechanism for the link
between Rasa3, talin and integrin activation (Fig. 6a;
P = 0.019). By contrast, no significant difference was detected in
the level of active GTP-bound Ras between Rasa3+/+ and
Rasa32/2 megakaryocytes (GTP-Ras mean fluorescence intensi-
ty: Rasa3+/+ megakaryocytes: 670.16117.9 arbitrary units (A.
U.); Rasa32/2 megakaryocytes: 706.2656.7 A. U.; P = 0.48; 3
independent experiments, 50 megakaryocytes analyzed per field,
2 fields per FLC culture). In order to confirm the important role
of Rap1 in the abnormal adherent phenotype of Rasa32/2
megakaryocyte, outside-in experiments were performed in the
presence of the Rap1 inhibitor GGTI-298, which is not active on
Ras. Addition of GGTI-298 to the culture medium completely
abolished the abnormal adhesion phenotype of Rasa32/2
megakaryocyte, but had no effect on the proplatelet phenotype
(Fig. 6b and 6c, and data not shown).
Altogether, these results indicate that the absence of Rasa3
increases Rap1 activation, and that Rap1 rather than Ras is
probably responsible for the abnormal Rasa32/2 adherent
megakaryocyte phenotype. Thus, increased Rap1 activation in
the absence of Rasa3 leads to constitutive activation of integrins
and increased outside-in signaling.
Altered platelet adhesion and activation in Rasa3+/2mice
Platelet adhesion and activation were analyzed on platelets
isolated from adult Rasa3+/+ and Rasa3+/2 mice (Fig. S4).
Rasa3+/2 platelets adhesion to BSA-coated plates was significantly
increased compared with Rasa3+/+ platelets (Fig. S4a). On
fibrinogen-coated plates, a trend for an increase adhesion was
detected in Rasa3+/2 platelets, but the difference with Rasa3+/+
platelets did not reach statistical significance (platelet counts per
field of view (FOV) (means 6 SEM); Rasa3+/+ platelets: 71618
platelets/FOV; Rasa3+/2 platelets: 114639 platelets/FOV;
P = 0.12). In resting condition, two platelet activation markers
were found altered in Rasa3+/2 platelets: the JON/A antibody
binding to Rasa3+/2 platelets and the percentage of CD62P P-
selectin positive Rasa3+/2 platelets were significantly increased, as
compared with Rasa3+/+ platelets (Fig. S4b and S4c). No
difference in the percentage of CD62P+ platelets was detected
after stimulation with ADP or CRP (Fig. S4c). In resting condition,
we found no difference in CD61 expression on Rasa+/+ and
Rasa3+/2 platelets, whereas CD41 expression was significantly
reduced on Rasa+/2 platelets; this data indicates that the increased
JON/A binding to Rasa3+/2 platelets is not simply a consequence
of an increased aIIb3 integrin expression (Fig. S4d). Finally,
platelet aggregation after ADP stimulation was similar in Rasa3+/+
and Rasa3+/2 platelets (Fig. S4e).
Altogether, these results indicate that Rasa3+/2 platelets present
adhesion and activation defects in resting conditions, suggesting
Figure 4. Abnormal actin cytoskeleton organization in megakaryocytes derived from Rasa32/2 fetal liver cell culture. Fetal liver cell
(FLC) were isolated from E12.5 Rasa3+/+ and Rasa32/2 embryos and cultured for 6 days with TPO. A. Rasa3+/+ (left bottom and top panels) and
Rasa32/2 (right bottom and top panels) adherent megakaryocytes in FLC culture after staining with phalloidin-TRITC (actin, red) and DAPI (green).
Confocal images were obtained at the bottom and the top of the same megakaryocyte. Graphs represent the fluorescence intensity (FI, scaled from 0
to 256) of phalloidin (actin) and DAPI stainings along the indicated line. The arrowheads on the images indicated the origin of the line. Twenty
megakaryocytes were analyzed in duplicate per FLC culture, 6 Rasa+/+ and 5 Rasa32/2 FLC cultures. Representative images are shown. B.
Quantification of the percentage of adherent Rasa3+/+ and Rasa32/2 megakaryocytes with a dotted (ie when F-actin is not detected) or a F-actin (ie
when stress fiber can be detected) phenotype (mean 6 SEM). Fifty megakaryocytes were analyzed in duplicate per FLC culture, 12 Rasa3+/+ and 10
Rasa32/2. Statistics (unpaired t test): ***: P,0.001.
doi:10.1371/journal.pgen.1004420.g004
Rasa3 in Megakaryopoiesis
PLOS Genetics | www.plosgenetics.org 6 June 2014 | Volume 10 | Issue 6 | e1004420
Figure 5. Altered inside-out and outside-in integrin signaling in Rasa32/2megakaryocytes. Fetal liver cell (FLC) were isolated from E12.5
Rasa3+/+ and Rasa32/2 embryos and cultured with TPO for 3 days. Megakaryocytes were enriched on a BSA-gradient, deprived of serum for 4 hours
and used in inside-out and outside-in integrin signaling assays. A. Inside-out aIIbb3 integrin signaling was investigated in megakaryocytes by
quantifying soluble FITC-fibrinogen (FITC-FNG) bound to the CD41+ cell surface by flow cytometry. Megakaryocytes were treated with or without
100 ng/ml TPO for 30 min. Specific binding was obtained after subtraction of the amount of soluble fibrinogen bound to the cell surface in the
presence of EDTA and was expressed relative to the maximum binding obtained in the presence of MnCl2. A. U.: arbitrary units. n. s.: non stimulated.
B., C., D. and E. Megakaryocytes were incubated for 18 hours on Poly-D-Lysine- (PDL), collagen-I- (COL-I) and fibrinogen- (FNG) coated plates in
medium containing 10% FBS. Number (B, mean 6 SEM) and diameter (C) of adherent megakaryocytes (MKs) was determined in 16 fields. Results are
representative of 3 independent experiments. D. The percentage of Rasa32/2 adherent megakaryocytes with a diameter over 50 mmwas significantly
increased, as compared with Rasa3+/+ megakaryocytes (mean 6 SEM of 3 independent experiments). E. Rasa3+/+ and Rasa32/2 PDL-adherent
megakaryocytes were stained with phalloidin-TRICT (actin, red), CD41-APC (magenta) and Talin-FITC (green). Confocal images were obtained from
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that a similar pathological mechanism is present both in
megakaryocytes and platelets.
Preleukemia in 4/24 SCID-Rasa32/2 mice
In the ,20% (4/24) remaining SCID-Rasa32/2 mice, a very
different phenotype was observed: a massive and homogeneous
cellular infiltration was detected in the bone marrow and spleen,
suggestive of a leukemia (Fig. 7a and data not shown). Adult naı¨ve
SCID mice intraperitoneally injected with 107 splenocytes isolated
from these SCID-Rasa32/2 mice did not develop a similar
proliferative disorder within 4 months after injection, suggesting
the presence of a preleukemia rather than a leukemia in these 4
SCID-Rasa32/2 mice (data not shown). No fibrosis was detected
in the bone marrow of these 4 SCID-Rasa32/2 mice. Flow
cytometry analysis with a panel of antibodies revealed that cells
massively infiltrating the bone marrow and the spleen were
positive for CD117/c-Kit, CD38 and Sca-1, and negative for all
other cell surface markers tested, including B220, CD3, MAR-1,
Gr1, Mac1, Ter119, CD71, CD4, CD34 and F4.80 (Fig. 7b, 7c
and data not shown). As expected, the percentage of B220+, CD3+,
Figure 6. Increased active Rap1 in Rasa32/2 megakaryocytes. Fetal liver cells (FLC) were isolated from E12.5 Rasa3+/+ and Rasa32/2 embryos
and cultured with TPO. A. Non adherent megakaryocytes on day 6 were analyzed for active, GTP-bound Rap1 by immunofluorescence using GST-
RalGDS-RBD and a FITC-conjugated mAb against GST. 3D reconstruction of Rasa3+/+ (left panels) and Rasa32/2 (right panels) megakaryocytes, along
with the pseudocolor fluorescence intensity scale. The graph represents the intensity of active Rap1 staining, expressed in arbitrary units (A. U.), in
Rasa3+/+ and Rasa32/2 megakaryocytes. Two independent experiments (quantification of 50 megakaryocytes per experiment,) with mean 6 SEM are
presented. Statistics (unpaired t test): *: P,0.05 B. and C. Addition of the Rap1 GGTI-298 inhibitor to the culture medium (3 mM) abolished the
abnormal adherent phenotype of Rasa32/2 megakaryocytes. Fetal liver cell (FLC) were isolated from E12.5 Rasa3+/+ and Rasa32/2 embryos and
cultured with TPO for 3 days. Megakaryocytes were enriched on a BSA-gradient and incubated for 18 hours on Poly-D-Lysine- (PDL) coated plates in
medium containing 10% FBS, in the presence or absence of GGTI-298. B. Representative confocal image of Rasa3+/+ and Rasa32/2 PDL-adherent
megakaryocytes after staining with CD41-APC (green) and DAPI (blue). Scale bar: 500 mm. C. The number of Rasa3+/+ and Rasa32/2 adherent
megakaryocytes was significantly decreased in GGTI-298 treated cells. Graph represents 2 independent experiments (mean 6 SEM). Statistics
(unpaired t test): **: P,0.01; ***: P,0.001.
doi:10.1371/journal.pgen.1004420.g006
the bottom of the cells. (i–iv): 46Digital magnification of phalloidin-TRICT and Talin-FITC merge. An increased Talin staining is observed in Rasa32/2
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Gr1int Mac1+, Ter119+ CD71+, CD41+ and F4.80+ cells was
significantly decreased in the bone marrow and the spleen of these
4 mice (data not shown). These 4 mice had a reduced survival
(survival range: 6–11 months after SCID mice irradiation/
reconstitution) and a splenomegaly (spleen weight range: 0.185–
1.062 g).
Collectively, these results indicate that about 20% of SCID-
Rasa32/2 mice develops a preleukemia with a massive infiltration
of bone marrow and spleen with CD117+ Sca-1+ CD38+ cells,
probably leading to bone marrow failure and premature death.
They also suggest that Rasa3 is a potential tumor suppressor gene,
acting may be on Ras, as proposed by Blanc et al. [18]. However,
the level of active, GTP-bound Ras was similar in CD117+/c-Kit+
hematopoietic stem cells derived from Rasa3+/+ and Rasa32/2
FLC cultures (Fig. 7d).
Discussion
Using a Rasa3 catalytic mutant in FLC and irradiated/
reconstituted SCID models, we show here that Rasa3 catalytic
activity controls megakaryocyte development and differentiation
into proplatelet forming megakaryocytes. In the irradiated/
reconstituted SCID model, these megakaryocyte alterations are
associated with thrombocytopenia, bleeding, regenerative anemia
and decreased survival, as well as with bone marrow fibrosis,
extramedular hematopoiesis and splenomegaly.
An increased percentage of mature megakaryocytes with an
abnormal morphology was detected in bone marrow cells from
irradiated/reconstituted SCID mice when Rasa3 catalytic activity
was inactivated. This increased percentage was associated with a
slightly decreased percentage of progenitors with megakaryocyte
potential, suggestive of a megakaryopoisis alteration. An obvious
megakaryopoiesis alteration was also detected in Rasa32/2 FLC
culture, where the number of CFU for immature megakaryocyte
was significantly decreased and associated with the presence of
numerous mature megakaryocytes. Ploidy in these Rasa32/2
abnormal megakaryocytes was also slightly altered. On the
contrary to active Ras level, level of active GTP-bound Rap1
was significantly increased in Rasa32/2 megakaryocytes. Inter-
estingly, the small GTPase Rap1 is both a Rasa3 substrate and a
well known regulator of integrin signaling in megakaryocytes and
platelets [2,25–29]. Both inside-out and outside-in integrin
signaling are controlled by Rap1, including aIIbb3 signaling.
Thus, the increased active GTP-bound Rap1 level detected in
Rasa32/2 megakaryocytes represents a plausible molecular
mechanism linking Rasa3 to integrin signaling and the altered
megakaryocyte development and differentiation. Indeed, altered
inside-out and outside-in integrin signaling in Rasa32/2 mega-
Figure 7. SCID-Rasa32/2 mice develop a CD117+ CD38+ Sca-1+ cell preleukemia. A. Representative images of a hematoxylin/eosin-stained
section of a femur from a SCID-Rasa3+/+ mouse and one of the four SCID-Rasa32/2 mice with a homogeneous cellular infiltration of the bone marrow
and the spleen (upper panels: magnification:620; lower panels: magnification:6100). B. CD117+ splenocyte percentages in SCID-Rasa3+/+ (n = 10)
and in the four SCID-Rasa32/2 mice with a preleukemia. Statistics (unpaired t test): ***: P,0.001. C. Representative flow cytometry analysis of bone
marrow cells from a SCID-Rasa3+/+ mouse (left histogram) and one of the four SCID-Rasa32/2 (right histogram) mice with a preleukemia, using a
CD117 antibody. The histograms show the CD117 fluorescence intensity and the relative number of cells (events). D. Fetal liver cells from Rasa3+/+
and Rasa32/2 E12.5 embryos were stained with a CD117 antibody and analyzed for active GTP-bound Ras level by immunofluorescence using GST-
Raf1-RBD and a FITC-conjugated mAb against GST. The graph represents the intensity of active GTP-bound Ras staining, expressed in arbitrary units
(A. U.), in Rasa3+/+ and Rasa32/2 CD117+ HSC. Mean 6 SEM are presented.
doi:10.1371/journal.pgen.1004420.g007
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karyocytes probably results in the adherence and motility defects
that we observed in this study. These defects may secondarily lead
to an abnormal distribution of megakaryocytes between osteo-
blastic and vascular niches and to altered megakaryopoiesis.
Constitutive activation of integrin signaling in Rasa32/2 mega-
karyocytes is associated with alteration in actin cytoskeleton
organization, including a lack of stress fiber assembly, in talin
recruitment to the plasma membrane and in cell adherence and
spreading that occurred independently of integrin ligands. These
alterations probably prevent terminal differentiation of Rasa32/2
megakaryocytes since megakaryocyte aIIbb3 and b1 integrins are
known to control proplatelet production and platelet release [30–
32]. Moreover, stress fiber assembly is known to require optimal
b1 integrin activation, a process also regulated by aIIbb3 integrin
[33,34]. In future work, it will be important to analyze Rasa32/2
platelets, since integrins play also important roles in these cells.
Our preliminary studies indicate that unstimulated Rasa3+/2
platelets have altered adhesion to BSA-coated plates and
activation, as compared with Rasa3+/+ platelets, thus mimicking
defect of Rasa32/2 megakaryocytes.
Interestingly, constitutive aIIbb3 integrin activation in human
megakaryocytes mimics most of the Rasa32/2 megakaryocyte
phenotypical traits. Indeed, in rare thrombocytopenic patients
with activating mutations in ITGA2B or ITGB3 genes, megakar-
yocyte spreading on fibrinogen is abnormal, with 50% of spread
cells showing a disordered actin distribution where focal adhesion
points are more evident than stress fibers [21]. Sustained and
substrate-independent activation of the outside-in aIIbb3 signaling
was detected in megakaryocytes of these patients, leading to
severely impaired proplatelet formation and congenital thrombo-
cytopenia [20–22]. It is noteworthy here that these patients do not
develop the entire Rasa32/2 phenotype, like megakaryocytosis
and bone marrow fibrosis, and its consequences. This discrepancy
suggests that Rasa3 has additional function beside the control of
integrin signaling, and/or that the enzyme has slightly different
roles in man and mouse.
In a recent report, Peters and collaborators have described a
new spontaneous mutant mouse with a missense mutation in the
Rasa3 protein [18]. The G125V Rasa3Scat mutation causes
mislocalization of the protein to the cytosol and phenotypical
traits that are clinically and biologically most often different from
SCID-Rasa32/2 and Rasa32/2 phenotypes (Table S5). Indeed,
Rasa3Scat/Scat mice have a cyclic phenotype of crisis-remission
with a first embryonic to P9 wave of lethality – which affect ,60%
of the mutant mice – followed by a second wave of lethality at P30
(affecting 94% of the first crisis survivors). This unexplained cyclic
phenotype is fully transferable via hematopoietic stem cells
injection into SCID or RAG2/2 mice, ruling out the possibility
that expression of the mutant Rasa3Scat protein outside the
hematopoietic system is responsible for the different phenotype
[18]. Another notable difference between Rasa3Scat/Scat and
SCID-Rasa32/2 mice is the presence of a delayed erythropoiesis
in the former mice. By contrast, in SCID-Rasa32/2 mice, many
hallmarks of regenerative anemia are present. It is noteworthy that
no bone marrow fibrosis nor extramedullar hematopoiesis have
been reported in the Rasa3Scat/Scat model, and no mechanism was
presented to explain the severe Rasa3Scat/Scat thrombocytopenia.
Finally, no evidence for predisposition to oncogenesis was
observed in Rasa3Scat/Scat mice, but the very small numbers of
homozygous mice that survive the second crisis period (,6% of
Scat/Scat newborns) may explain this difference and preclude
more extensive analysis. The cause of the major differences
between the Rasa3Scat/Scat and SCID-Rasa32/2 phenotypes is
currently not known, but may be due to the different mutation
present in the Rasa3 protein - affecting protein localization and
enzymatic activity, respectively - and/or to the different genetic
background of the two models. Indeed, relocalization of the
Rasa3Scat/Scat protein from the membrane to the cytosol may
eventually create a new function in this cell compartment and lead
to phenotypic alterations that are not present in mice expressing a
catalytically-inactive and truncated Rasa3 protein.
About 20% of SCID-Rasa32/2 mice develop a preleukemia
characterized by a massive infiltration of bone marrow and spleen
with CD117+ Sca-1+ CD38+ cells, a phenotype very similar to
acute myeloid leukemia in man. The exact mechanism of this
preleukemia was not defined in this work, but active GTP-bound
Ras level was similar in Rasa3+/+ and Rasa32/2 fetal liver
CD117+ hematopoietic stem cells. However, our studies in the
human K562 leukemic cell line which overexpresses Rasa3 suggest
that Rasa3 is a probable negative regulator of proliferation in these
cells (Fig. S5). Alternatively, it has been reported that b1 and b3
integrin signaling regulates the balance among hematopoietic stem
cell self-renewal, differentiation and quiescence in the osteoblastic
niche [35,36]. Furthermore, b1 and b3 integrins can regulate stem
cell functions via direct or indirect participation in cellular
signaling [37], providing a potential mechanism to explain the
predisposition to preleukemia in a minor percentage of SCID-
Rasa32/2 mice.
In conclusion, our results demonstrate that mice with a catalytic
inactivation of Rasa3 protein in the hematopoietic system develop
a lethal syndrome characterized by defects during megakaryocyte
development and differentiation, and leading to a severe
thrombocytopenia. This syndrome is associated with Rap1 and
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Mice
Rasa32/2 mice with Rasa3 exons 11 and 12 replaced by a
neomycin resistance cassette express a catalytically-inactive Rasa3
truncated protein [16]. These mice were analyzed on a hybrid
129/SvJ6C57BL/6J genetic background. C.B.-17 SCID mice
were purchased from Charles River, Belgium. All mice were bred
in a specific pathogen free facility at the GIGA–Research Centre.
The Rasa3 genotype was determined by PCR as previously
described [16]. For reconstitution, 4–6 week-old C.B.-17 SCID
mice were irradiated (200 rad) and a total homogenate of E12.5
fetal liver cells (FLC) obtained from Rasa3 embryos was
intravenously injected. SCID-Rasa32/2 mice were killed and
analyzed either when moribund (ie presenting a severely reduced
mobility and/or feeding incompatible with a more than 2 days
survival) or 14 months after irradiation/reconstitution.
Fetal liver cells (FLC) isolation and megakaryocyte
differentiation
Individual liver was recovered from E12.5 embryo and single
cell suspension was prepared by passage through a 23-gauge
needle. Recovered cells were cultured in DMEM (Gibco)
supplemented with 10% heat-inactivated FBS, 2 mM L-Gluta-
mine, 50 U/mL Penicillin, 50 ng/mL streptomycin, 0.1 mM
nonessential amino acids and 50 ng/ml of recombinant mouse
TPO for megakaryocyte differentiation (PreProtech).
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Bone marrow explants analysis
Bone marrow from SCID-Rasa3+/+ and SCID-Rasa32/2
femurs were flushed with PBS. The marrow was cut in 1 mm
transverse sections and placed in an incubation chamber
containing complete DMEM medium. Chamber was maintained
at 37uC for 6 h. Megakaryocytes at the periphery of the explant
were observed under a confocal microscope (Nikon A1R, 206
objective). Each experiment was performed in duplicates. One
transversal section was used to determine by flow cytometry the
number of CD41+ cells present in the explant. Images were
acquired sequentially at 10 min intervals and processed with NIS-
software and ImageJ. Three mice from each genotype were
analyzed.
Inside-out aIIbb3 integrin and outside-in integrins
signaling in megakaryocytes
FLC from Rasa3+/+ and Rasa32/2 embryos were cultured in
the presence of TPO as described above. On day 3, recovered cells
were enriched for mature megakaryocytes on a 1.5–3% bovine
serum albumin (BSA) gradient under gravity for 45 min at room
temperature. The percentage of mature megakaryoctes in the
enriched population was always over 70%. Cells were resuspended
in Tyrode’s buffer containing 1 mM CaCl2 and 1 mM MgCl2 for
3 h. For inside-out integrin signaling, cells were incubated for
30 min at room temperature with FITC-fibrinogen (250 mg/ml)
and 100 ng/ml TPO, 1 mM MnCl2 or nothing, in the presence or
absence of 10 mM EDTA. After a 10-fold dilution with PBS
containing 1 mg/ml propidium iodide, fibrinogen binding was
quantified by flow cytometry [22]. Specific fibrinogen binding was
defined as binding that was inhibited by 10 mM EDTA. To
compare independent experiments, specific fibrinogen binding was
expressed as a percent of maximal binding obtained in the
presence of 1 mM MnCl2, an activator of integrins. For outside-in
integrin signaling, coverslides were coated with murine fibrinogen
(100 mg/ml), collagen-I (35 mg/ml) or Poly-D-Lysine (PDL,
15 mg/ml) for 1 h at room temperature, blocked with denatured
BSA (5 mg/ml) for 30 min and washed with PBS before use. Cells
(256103) were incubated for 18 h on the indicated substrate and
non adherent cells were removed. Adherent cells were fixed in
10% formalin, permeabilized with 0.2% Triton X-100 in PBS and
stained as described below. Cells were then analyzed by confocal
microscopy and ImageJ Software. For Rap1 inhibitor studies,
purified mature megakaryocytes were cultured over PDL coated-
plates as in outside-in experiments in the presence of 3 mM GGTI-
298 (Sigma) or DMSO as control. Adherent cells were fixed in
10% formalin, permeabilized with 0.2% Triton X-100 in PBS and
stained as described above. Cells were then analyzed by confocal
microscopy and ImageJ Software.
Flow cytometry analysis and antibodies
A single-cell suspension of femur bone marrow was prepared by
flushing the bones with PBS followed by gentle disaggregation
through Pasteur pipette. Cells were released from spleen by gentle
disruption with a piston of syringe. Spleen cells were treated with
ACK buffer to lyse erythrocytes and washed once with PBS. Cells
were incubated with 2.4G2 to saturate Fcc receptors II and IIIa
before staining with primary and secondary antibodies in PBS
containing 0.1% FBS and 0.1% NaF for 20 min, and washed with
the same solution before flow cytometric analysis on a FC 500
(Beckman Coulter). Cell counts were determined by adding
fluorospheres (Flow-Count Fluorospheres, Beckman Coulter) to
the cell suspension, as described by the manufacturer. The
following anti-mouse biotinylated or fluorochrome-conjugated
antibodies were obtained from BD Pharmingen: anti-CD3e,
anti-CD71, anti-CD41 and anti-CD117. Anti-B220, anti-F4/80,
anti-IgM, anti-Mac1, anti-Sca-1, anti-CD34, anti-CD38, anti-
Ter119, anti-CD41 and anti-Gr1, as well as streptavidine-
cychrome 5 were obtained from eBioscience. Anti-FceRIa (Mar-
1) was obtained from O. Leo’s laboratory (Universite´ Libre de
Bruxelles, Belgium). JON/A antibody was obtained from Emfred
Analytics. Fetal liver cell were analyzed on a FACS CantoII
(Beckman Coulter). For hematopoietic stem and megakaryocyte
progenitor cells staining, anti-mouse biotinylated or fluorochrome-
conjugated antibodies specific for Ter-119, Gr1, Mac1, CD4,
CD8, CD5, IL7Ra, B220 and c-Kit (CD117) were used to define
the c-Kit+ Lin2 cell population [19,38]. Then, anti-Sca-1, anti-
CD34 and anti-Flk2/Flt3 were used to define the hematopoietic
stem cells, whereas anti-Sca-1, anti-FcRcII/III and anti-CD150
were used to define the megakaryocytes progenitor cells (all
antibodies were from eBioscience, except anti-Flk2, from BD
Pharmingen and anti-CD150, from BioLegend). Streptavidin
phycoerythrin-Texas Red was from Invitrogen. Debris, aggregates
and propidium iodide-positive dead cells were first excluded. Cells
were analyzed using an LSRII flow cytometer (Becton Dickinson).
Data were analyzed with FlowJosoftware (Tree Star, Ashland,
OR).
Ploidy assay
Fetal liver cells were stained for CD41 as described above and
fixed with 5% formalin for 15 min. Cells were permeabilized in
PBS containing 0.25% Tx-100 for 5 min at 4uC. DNA was stained
with DAPI for 20 min and DNA content in CD41+ cells was
determined by flow cytometry.
Histology
Spleen and liver were fixed in paraformaldehyde 4% and
embedded in paraffin following standard procedures. Femurs were
fixed in paraformaldehyde 3.7%, decalcified in 0.5M EDTA pH 8
for one week and then processed as spleen and liver. Serially cut 5-
mm-thick sections were stained with hematoxylin/eosin or Sirius
Red (for femur) according to standard protocols.
Immunohistochemistry of spleen and femur
Spleen was processed as described and sections were stained
with an anti-B220 antibody [39]. Femur sections were stained with
a rabbit polyclonal anti-von Willebrand Factor (vWF) antibody
from Dako. For quantification of megakaryocytes in osteoblastic
and vascular niches, the whole diaphysis of three consecutive
femur sections was scanned with a conventional microscope (206
objective) for vWF+ cells, as described [40]. Megakaryocytes in the
osteoblastic niche were calculated as the number of megakaryo-
cytes in contact with the endosteal border. Megakaryocytes in the
vascular niche were calculated as the number of megakaryocyte
per vessel border. Osteoblastic and vascular borders were
calculated with ImageJ software. Results are means 6 SEM of 3
mice per genotype.
Blood analysis
Platelet counts were determined with Unopette (Becton
Dickinson). Red cells, total white cells, lymphocytes, neutrophils,
eosinophils, basophils, hemoglobin, hematocrit and red cell
volume were quantified with a Cell Dyn 3500 analyzer (Abott
Diagnostic). Serum erythropoietin and thrombopoietin levels were
determined with ELISA mouse EPO and mouse TPO Quantikine
kits (R&D Systems). Blood smears were stained with Giemsa’s,
methylene blue and Romanowsky’s solutions.
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Immunofluorescence and confocal microscope analysis
Immunofluorescence studies using conventional and confocal
microscopes were performed on total FLC cultured in the
presence of TPO, on purified mature megakaryocytes and on
FL hematopoietic stem cells. Cells were fixed in 5% formalin for
15 min, washed, permeabilized with 0.2% Tx-100 in PBS
containing 2% of FBS for 15 min and incubated 1 h at room
temperature with APC-conjugated anti-CD41 (MW Reg30,
eBioscience) for megakaryocyte or CD117 (BD Pharmingen) for
HSC. Active, GTP-bound Rap1 or Ras immunofluorescence was
detected using GST-RalGDS-RBD or GST-Raf1-RBD, respec-
tively, and a FITC-conjugated mAb against GST (Santa Cruz) as
described [41] Negative controls included the omission of GST-
RalGDS-RBD/GST-Raf1-RBD, the substitution of GST-
RalGDS-RBD/GST-Raf1-RBD with GST and the substitution
of the anti-GST antibody with an irrelevant FITC-conjugated
mouse IgG. After several washes, phalloidin-TRICT (Sigma) and
DAPI (Sigma) were added for 20 min in PBS. After 3 washes in
PBS, samples were mounted in ProLong (Invitrogen) for
observation under a confocal microscope (NikonA1R) and/or an
epifluorescence microscope (Nikon Eclipse 90i). For active Rap1
or Ras images, z-sections of 0.150 microns were acquired from
megakaryocytes or HSC. Pseudocolor scale was used to depicture
the intensity of active Rap1 or Ras staining along the cell
membrane. ImageJ was used to quantify the intensity of active
Rap1 or Ras staining on each cell. All images were acquired and
analyzed in the same conditions.
For immunofluorescence studies of adherent megakaryocyte,
cells were fixed with 10% formalin for 15 min, washed,
permeabilized with 0.2% Tx-100 in PBS containing 2% of FBS
for 15 min and incubated 1 h at room temperature with the
indicated primary and secondary antibodies. After several washes,
phalloidin-TRICT (Sigma) and DAPI (Sigma) were added for
20 min in PBS. After 3 washes in PBS, samples were mounted in
ProLong (Invitrogen) for observation under a confocal microscope
(NikonA1R). The following antibodies were used: APC-conjugated
anti-CD41 (MW Reg30, eBioscience), anti-Rap1 (Millipore), anti-
Talin-FITC and anti-rabbit-alexa 488.
CFU-Mk assay
A collagen-based system (MegaCult-C, StemCell Technologies,
Inc.) was used for the colony assay. Briefly, 1.256105 freshly
isolated fetal liver cells were resuspended in IMDM completed
with recombinant mouse TPO (50 ng/ml), IL-3 (20 ng/ml) and
IL-6 (10 ng/ml), followed by addition of cold collagen. Suspension
was dispensed into 2 wells of a four chamber slide (Millipore) for
duplicates. Cultures were kept at 37uC in a 5% CO2 atmosphere
for 3 days. The collagen matrix was then fixed in a methanol–
acetone solution (1:3), at room temperature for 20 min for colony
fixation. Slides were then allowed to air dry for 15 min and stained
for Acetylcholinesterase. For scoring, acetylcholinesterase-positive
colonies with 3 or more immature megakaryocytes of about 10 mm
of diameter were scored as CFU-Mk. Mature megakaryocytes
averaged approximately 30 mm in diameter.
Preparation of mouse washed platelets
Eight- to twelve-week old male mice were bled under sodium
pentobarbital anesthesia from the retro-orbital plexus. Blood was
collected on acid citrate dextrose (ACD: 93 mM Na3-citrate,
7 mM citric acid, 14 mM dextrose, pH 6.0) containing 1 U/ml
apyrase (Grade I, Sigma) in a volume ratio of ACD to blood of 1:6.
Blood was centrifuged for 5 s at 8006g followed by 5 min at 1006
g to obtain platelet rich plasma (PRP). PRP was diluted 3 fold in
ACD containing 1 U/ml apyrase and centrifuged at 10006g. The
platelet pellet was resuspended at a concentration of 36108/ml in
Tyrode’s buffer (137 mM NaCl, 12 mM NaHCO3, 2 mM KCl,
0,34 mM Na2HPO4, 1 mM MgCl2, 5,5 mM glucose, 5 mM
Hepes, 0.35% BSA).
Platelet adherence assay
In order to test the adhesion of unstimulated platelets to BSA-
coated surface, 3.56106 platelets in 300 ml of tyrode’s buffer were
added to each well of a 8 chambers slide (Millipore) and incubated
for 45 min in a CO2 incubator at 37uC. Adherent platelets were
washed twice with PBS, fixed with 10% formalin, and stained with
phalloidin-TRICT.
Flow cytometry analyses of platelet activation
Washed platelets were stimulated or not with ADP (25 mM) or
collagen-related peptide (CRP) (1 mg/ml),under non-stirring con-
ditions. After 15 minutes of activation, saturating concentrations
of FITC-conjugated CD62 anti-P-selectin and PE-conjugated
JON/A antibodies were added to the platelets, and incubations
were continued for additional 15 minutes in the dark. Samples
were fixed before the analysis with a FACS Calibur flow cytometer
(BD Biosciences).
Platelet aggregation analysis
Light transmission was recorded during platelet aggregation
induced by ADP (50 mM) in the presence of 2 mM CaCl2 on a
Chrono-Log Lumi-Aggregometer (Havertown, PA).
Proliferation assay on a Rasa3-inducible K562 leukemic
cell line
The Rasa3-tet-ON-inducible K562 cell line was generated by
GEnTarget Inc. Briefly, Rasa3 expression and TetR repressor
lentiviruses were generated and cotransduced in K562 cell by the
company. K562 mutant cell line (K562-Rasa3) was cultured in
IMDM supplemented with 10% heat-inactivated FBS, 2 mM L-
Glutamine, 50 U/mL Penicillin, 50 ng/mL streptomycin,
0.1 mM nonessential amino acids, 10 mg/ml blasticidin and
1 mg/ml puromycin. Treatment of K562-Rasa3 cells with
tetracycline (2 mg/ml) induced Rasa3 expression from the
lentiviral constructs after 48 h. For the proliferation assay,
46105 cells per ml were cultured in the absence or presence of
tetracycline for 12 days. At the indicated days, number of alive
cells was counted with a hemocytometer. Death cells were
excluded by trypan blue staining. Rasa3 expression was confirmed
by western blot. Two independent experiments were performed in
duplicates-triplicates.
Statistics
Results are expressed as means 6 SEM. Statistical analyses
were performed with Graphpad Prism 3.0. The test used for each
experiment is described in the corresponding legend. For each test,
a difference of P,0.05 was considered significant.
Supporting Information
Figure S1 Bone marrow histology of SCID-Rasa3+/+ and
SCID-Rasa32/2 mice. (A) Sirius Red-stained sections of age-
matched SCID-Rasa3+/+ and moribund SCID-Rasa32/2 femurs.
Numerous collagen trabeculae are detected in the cavity of the
mutant femur, while the cavity of SCID-Rasa3+/+ femur was free
of collagen trabeculae. (B) Hematoxylin/eosin-stained sections of
femur isolated from age-matched SCID-Rasa3+/+ and moribund
SCID-Rasa32/2 mice. Asterisks indicate megakaryocytes. A
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similar cell density is observed in the cavity of SCID-Rasa3+/+ and
SCID-Rasa32/2 femurs. Scale bars: 50 mm.
(TIF)
Figure S2 Abnormal splenic architecture and liver hematopoi-
esis in SCID-Rasa32/2 mice. Sections of age-matched SCID-
Rasa3+/+ (left) and moribund SCID-Rasa32/2 (right) spleen were
stained with (A) hematoxylin/eosin (H/E) or (B) a B220 antibody
(B220). In SCID-Rasa32/2 spleen, the limits between red and
white pulps are ill defined and the red pulp is infiltrated by cells of
various sizes; the B cell compartment is also disorganized. C.
Sections of age-matched SCID-Rasa3+/+ (left) and moribund
SCID-Rasa32/2 (right) liver were stained with hematoxylin/eosin
(H/E). Liver hematopoiesis (arrow) is observed in SCID-Rasa32/
2 mice, but never in SCID-Rasa3+/+ mice. Inset: same image at
higher magnification.
(TIF)
Figure S3 Regenerative anemia in SCID-Rasa32/2 mice.
Blood analyses were performed on age-matched SCID-Rasa3+/+
and moribund SCID-Rasa32/2 mice. Mean 6 SEM of red cell
concentration (A), hemoglobin concentration (B), hematocrit (C)
and red cell volume (D) in SCID-Rasa3+/+ (black columns, n = 7)
and SCID-Rasa32/2 (white columns, n = 11) mice. Representa-
tive images of anisocytosis with polychromasia (E), of Howell-Jolly
bodies (F), of increased reticulocytosis (G) and of metarubricytes
(H) observed on blood smear from moribund SCID-Rasa32/2
mice. These alterations were not observed in age-matched SCID-
Rasa3+/+ mice. I. Mean 6 SEM of erythropoietin concentrations
in age-matched SCID-Rasa3+/+ (black column, n = 8) and
moribund SCID-Rasa32/2 (white column, n = 8) mice. Together,
these alterations are classically associated with a regenerative
anemia. Scale bars: 5 mm. Statistics (unpaired t test): *: P,0.05; **:
P,0.01.
(TIF)
Figure S4 Altered platelet adherence and activation in adult
Rasa3+/2 mice. Unstimulated platelets were isolated from 8 week-
old Rasa3+/+ and Rasa3+/2 mice. A. After 45 min, an increased
number of Rasa3+/2 platelets adhered to BSA-coated plates, as
compared with Rasa3+/+ platelets. Mean 6 SEM of platelet
counts per field of view (FOV) from two independent experiments
performed in duplicate are represented. Statistics (unpaired t test):
**: P,0.01. Representative images of Rasa3+/+ and Rasa3+/2
adherent platelets after 45 min, stained with phalloidin-TRICT
(actin, red). B. Mean 6 SEM of the mean fluorescence intensity
(MFI) of the JON/A antibody binding to the high affinity
conformation of the integrin aIIbb3 on Rasa3+/+ and Rasa3+/2
platelets in resting condition. Results are representative of three
separate experiments. Statistics (unpaired t test): *: P,0.05. C.
Mean 6 SEM of the percentage of CD62P+ platelets in non
stimulated condition (n. s.) and after ADP (25 mM) or CRP (1 mg/
ml) stimulation. Results are representative of three separate
experiments. Statistics (unpaired t test): *: P,0.05. D. Mean 6
SEM of the mean fluorescence intensity of CD61 and CD41
expression on Rasa3+/+ and Rasa3+/2 platelets. Results are
representative of three separate experiments. Statistics (unpaired t
test): ***: P,0.001. E. Platelet aggregation assay revealed no
aggregation defect in Rasa3+/2 platelets in response to ADP
(50 mM), as compared with Rasa3+/+ platelets. Results are
representative of three separate experiments.
(TIF)
Figure S5 Effect of Rasa3 expression on K562 leukemic cell
proliferation. Rasa3 expression in a mutant K562 leukemic cell
line was induced by adding tetracycline in the culture medium for
12 days. At days 7 and 12, Rasa3 expression was analyzed by
western blot and the number of living cells was measured with a
hemocytometer. Graph represents the number of cells in the
culture at days 7 and 12 (mean 6 SEM, 3 independent
experiments, each performed in duplicates/triplicates). Statistics
(One-way anova): * P,0.05.
(TIF)
Table S1 Total numbers of T and B cells were determined in
the spleen of SCID-Rasa3+/+, SCID-Rasa3+/2 and SCID-
Rasa32/2 mice 6 weeks after irradiation/reconstitution by flow
cytometry on the basis of 145-2C11 and B220 expression. A
trend for higher B220+ B cell number was observed in SCID-
Rasa32/2 mice as compared with SCID-Rasa3+/+ mice, but the
difference did not reach statistical significance (P = 0.053,
unpaired t test). Red blood cell, blood platelet and bone marrow
megakaryocyte counts as well as spleen weight were also analyzed
6 weeks after irradiation/reconstitution. No significant difference
was observed between SCID-Rasa3+/+ and SCID-Rasa32/2
mice. Megakaryocyte counts per field of view were obtained with
a 620 objective, 3 fields per mouse, 5 SCID-Rasa3+/+ and 4
SCID-Rasa32/2 mice.
(DOC)
Table S2 Bone marrow cells were isolated from SCID-Rasa3+/+
and SCID-Rasa32/2 mice 2 months after irradiation/reconstitu-
tion, incubated with antibodies directed against cell surface
markers and analyzed by flow cytometry for the percentage of
cells within the bone marrow cells or within a subpopulation of
bone marrow cells defined by specific markers.
(DOC)
Table S3 Age-matched SCID-Rasa3+/+ and moribund SCID-
Rasa32/2 mice were analyzed for their total number of nucleated
splenocytes and, after flow cytometry with relevant antibodies, for
their percentages (%) and cell numbers (n) of splenic mature
(macrophages, T and B cells) and immature (megakaryocytes,
myeloid cells, hematopoietic progenitors and erythroblasts) cells.
Results indicate that in SCID-Rasa32/2 mice, total number of
nucleated splenocytes as well as percentage and number of
immature splenic cells are significantly increased, consistent with a
markedly increased hematopoiesis in the spleen of these mice, as
compared with SCID-Rasa3+/+ mice. By contrast, the percentage
of mature cells is decreased in the spleen of SCID-Rasa32/2 mice,
as compared with SCID-Rasa3+/+ mice, although their number is
increased, a probable consequence of the increased hematopoiesis
in this organ.
(DOC)
Table S4 Age-matched SCID-Rasa3+/+ and moribund SCID-
Rasa32/2 mice were analyzed for their total number of white cells
and circulating neutrophils, lymphocytes, monocytes and eosino-
phils on Giemsa-stained blood smears.
(DOC)
Table S5 Genetic, biological and phenotypical differences
between Rasa3Scat/Scat, Rasa32/2 and SCID-Rasa32/2 mice.
(DOC)
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